Physician profile
George B Morris
NPI 1598722589
$1,450.86
in general payments reported to CMS, 2019-2025
20 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $275 · 2021: $135 · 2022: $392 · 2023: $61.61 · 2024: $58.87 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.64 | 2019-2022 | |
| Pfizer INC. | $202.24 | 2019-2022 | |
| Covidien LP | $145.98 | 2019 | |
| Dilon Technologies, INC. | $140.78 | 2025 | Hemoblast Bellows |
| Astellas Pharma US INC | $116.15 | 2023-2024 | Veozah |
| Scynexis, INC. | $104.23 | 2021-2022 | |
| Biom'Up France Sas | $82.80 | 2020 | |
| Intuitive Surgical, INC. | $74.49 | 2022-2025 | |
| Organon LLC | $50.77 | 2021-2022 | |
| Therapeuticsmd, INC. | $39.85 | 2020-2022 | |
| Momentis Surgical INC. | $37.00 | 2022 | |
| Merck Sharp & Dohme LLC | $31.46 | 2019-2020 | |
| Evofem Biosciences, INC. | $30.71 | 2021-2022 | |
| Millicent US INC | $29.78 | 2020-2025 | Femlyv, Femring |
| Avion Pharmaceuticals | $23.86 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $23.11 | 2020-2021 | |
| Coopersurgical, INC. | $20.86 | 2019 | |
| Agile Therapeutics, INC. | $18.25 | 2021 | |
| Lupin INC. | $14.57 | 2020 | |
| Mayne Pharma Commercial LLC | $4.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.